{"title":"How a patent eligibility case could affect personalized medicine.","authors":"Joanna T Brougher","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Personalized medicine may be in danger as the doctrine of patent eligibility -which determines technological innovations that warrant patent protection -faces legal challenges. Diagnostic tests, gene patents, and more are at stake.</p>","PeriodicalId":89534,"journal":{"name":"Biotechnology healthcare","volume":"7 1","pages":"23-6"},"PeriodicalIF":0.0000,"publicationDate":"2010-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873727/pdf/bth07_1p023.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biotechnology healthcare","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Personalized medicine may be in danger as the doctrine of patent eligibility -which determines technological innovations that warrant patent protection -faces legal challenges. Diagnostic tests, gene patents, and more are at stake.